Minerva Neurosciences (NERV) Research & Development (2013 - 2026)
Minerva Neurosciences' Research & Development came in at $7.19 million for Q2 2026, up 453.7% from $1.3 million a year earlier and up 36.8% from the prior quarter.
Powered by 
Analysis
Minerva Neurosciences (NERV) Research & Development (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Minerva Neurosciences reported Research & Development of $15.54 million, up 137.9% year-over-year; for FY2025, it came in at $5.76 million, down 51.6% from FY2024.
- Research & Development has declined in each of the last four years, with a five-year compound annual growth rate of -23.5% (FY2020 to FY2025).
- Going back by year, Research & Development was $11.9 million in FY2024 (-6.3%), $12.71 million in FY2023 (-13.3%), $14.65 million in FY2022 (-54.3%) and $32.04 million in FY2021 (+45.4%).
- The Q2 2026 figure represents the highest quarterly Research & Development since Q4 2021.
- Year-over-year, Research & Development has increased for three consecutive quarters, with growth averaging 57.6% over the last eight quarters.
- The fastest year-over-year change in Research & Development over five years came in Q2 2026 (growth of 453.7%), and the weakest in Q4 2022 (a decline of 83.0%).
- Business Quant data shows NERV's Research & Development at $5.25 million (Q1 2026), $2.17 million (Q4 2025) and $925,377 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Minerva Neurosciences | 121.62 Mn | -126.30 Mn | - | 7.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.19 Mn |
| Mar 31, 2026 | 5.25 Mn |
| Dec 31, 2025 | 2.17 Mn |
| Sep 30, 2025 | 925,377.00 |
| Jun 30, 2025 | 1.30 Mn |
| Mar 31, 2025 | 1.36 Mn |
| Dec 31, 2024 | 1.98 Mn |
| Sep 30, 2024 | 1.89 Mn |
| Jun 30, 2024 | 3.86 Mn |
| Mar 31, 2024 | 4.17 Mn |
| Dec 31, 2023 | 4.72 Mn |
| Sep 30, 2023 | 3.44 Mn |
| Jun 30, 2023 | 1.89 Mn |
| Mar 31, 2023 | 2.65 Mn |
| Dec 31, 2022 | 3.19 Mn |
| Sep 30, 2022 | 2.37 Mn |
| Jun 30, 2022 | 4.13 Mn |
| Mar 31, 2022 | 4.96 Mn |
| Dec 31, 2021 | 18.75 Mn |
| Sep 30, 2021 | 4.51 Mn |
API Access
Minerva Neurosciences Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=NERV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "NERV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=NERV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();